The lncRNA RMST is drastically downregulated in anaplastic thyroid carcinomas where exerts a tumor suppressor activity impairing epithelial-mesenchymal transition and stemness

Thyroid cancer is the most prevalent endocrine malignancy and comprises a wide range of lesions subdivided into differentiated (DTC) and undifferentiated thyroid cancer (UTC), mainly represented by the anaplastic thyroid carcinoma (ATC).

This is one of the most lethal malignancies in humankind leading invariably to patient death in few months.

Then, a better comprehension of the mechanisms underlying the development of ATC is required to set up new therapeutic approaches.

Long non-coding RNAs (lncRNAs) are transcripts over 200 nucleotides in length that do not code for proteins.

They show a strong regulatory function at both transcriptional and post-transcriptional level and are emerging as key players in regulating developmental processes.

Their aberrant expression has been linked to several biological processes, including cancer, making them potential diagnostic and prognostic markers.

We have recently analyzed the lncRNA expression profile in ATC through a microarray technique and have identified rhabdomyosarcoma 2-associated transcript ( RMST ) as one of the most downregulated lncRNA in ATC.

RMST has been reported to be deregulated in a series of human cancers, to play an anti-oncogenic role in triple-negative breast cancer, and to modulate neurogenesis by interacting with SOX2.

Therefore, these findings prompted us to investigate the role of RMST in ATC development.

In this study we show that RMST levels are strongly decreased in ATC, but only slightly in DTC, indicating that the loss of this lncRNA could be related to the loss of the differentiation and high aggressiveness.

We also report a concomitant increase of SOX2 levels in the same subset of ATC, that inversely correlated with RMST levels, further supporting the RMST/SOX2 relationship.

Finally, functional studies demonstrate that the restoration of RMST in ATC cells reduces cell growth, migration and the stemness properties of ATC stem cells.

In conclusion, these findings support a critical role of RMST downregulation in ATC development.